Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity.
about
Toxic hepatitis in occupational exposure to solventsNon-alcoholic fatty liver disease: what the clinician needs to know.Role of endoplasmic reticulum stress in drug-induced toxicityMitochondrial fatty acid oxidation in obesityRegulation of mitochondrial function by voltage dependent anion channels in ethanol metabolism and the Warburg effectRole of mitochondria in alcoholic liver diseaseFunctional roles of protein nitration in acute and chronic liver diseasesUridine prevents fenofibrate-induced fatty liverEvidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in manAbnormal fatty acid metabolism in childhood spinal muscular atrophyDevelopment and characterization of an animal model of carnitine deficiencyPharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasisFatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytesEthanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytesChronic liver injury induced by drugs: a systematic review.Associations of gender and age with the reporting of drug-induced hepatic failure: data from the VigiBaseā¢.Hematological manifestations of primary mitochondrial disorders.Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice.Alcoholic liver injury: influence of gender and hormonesProteomics investigations of drug-induced hepatotoxicity in HepG2 cells.Adverse effects of antiepileptic drugs.S-nitroso-N-acetylcysteine ameliorates ischemia-reperfusion injury in the steatotic liverHigh-dose clevudine impairs mitochondrial function and glucose-stimulated insulin secretion in INS-1E cells.Mechanisms of drug-induced liver injury: from bedside to bench.Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver diseaseChildren versus adults: pharmacokinetic and adverse-effect differences.Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion.Transition between acute and chronic hepatotoxicity in mice is associated with impaired energy metabolism and induction of mitochondrial heme oxygenase-1.Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States.Review article: breath testing for human liver function assessment.Zidovudine (AZT) and hepatic lipid accumulation: implication of inflammation, oxidative and endoplasmic reticulum stress mediators.Acute ethanol causes hepatic mitochondrial depolarization in mice: role of ethanol metabolism.The role of investigative molecular toxicology in early stage drug development.Mechanical ventilation interacts with endotoxemia to induce extrapulmonary organ dysfunction.Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistanceLong term effects of high fat or high carbohydrate diets on glucose tolerance in mice with heterozygous carnitine palmitoyltransferase-1a (CPT-1a) deficiency: Diet influences on CPT1a deficient mice.A new hepadnavirus endemic in arctic ground squirrels in Alaska.Developmental bisphenol A (BPA) exposure leads to sex-specific modification of hepatic gene expression and epigenome at birth that may exacerbate high-fat diet-induced hepatic steatosis.Genomics, proteomics and metabonomics in toxicology: hopefully not 'fashionomics'.Hepatic mitochondrial alterations and increased oxidative stress in nutritional diabetes-prone Psammomys obesus model
P2860
Q22305492-728CDCC5-C343-40C1-B81D-AEAB6C3BFAA9Q24563068-B173F504-4A28-4673-B643-780DC4C43FAFQ26765518-6B1EE483-16BF-46A5-8481-2D823D51166AQ26820838-750EE870-637B-409D-9992-7C93DA08B69DQ26827829-37379429-D4FC-43CB-B1D7-2625E05EC3EBQ26864954-B96FEBF8-ED8F-4700-A959-331392C9E236Q27008888-10DFB6B8-3DAE-456D-BC0C-5A1557A8E285Q27325516-6867F338-0FD4-4882-B280-EB2BC2B14F3DQ28069617-75F5C708-6648-4489-BB2D-C31EE6ED1D71Q28138438-332FF305-7427-403B-B204-B031C452C603Q28204749-2A3B86B4-500C-4BAA-9EFD-F69228F227E4Q28481509-AE25B6AA-BBAC-4782-B636-6EAFD88ECFBEQ28566783-1B0B14F7-8211-4AF8-B4A4-7135111C3FFBQ28579862-A0F266D1-968F-4964-B6E4-4DB767E1601BQ30278737-1A43570F-03CE-431D-A917-FCC2AD3CEBEDQ30594318-99F1D232-9B5B-4C1E-9D12-9444FC2A9400Q33375931-10CCCE1C-87DF-4F35-8FC2-5AF0F1DD35C6Q33634147-DEE180FD-F44C-4CB5-9AAC-0A000DCDADDAQ33742471-1CD6B8F8-6D80-409D-874E-F7C5586242C9Q33773197-A20EE6C1-0250-4475-BA1B-8B2455762D34Q33961524-29302128-F34F-4EA3-A0C4-0BB361CBC8AAQ34023487-DEC6AD90-9471-4B2E-8CF7-2F0A90AC9744Q34121999-4EF2A9C6-9C1B-4F1D-AEFE-2F53A376D9E9Q34169362-ED2809EB-25C7-460A-938E-900439C4E762Q34200914-952BD6EF-D3FB-42BA-B7E1-CA985BC2C38AQ34680689-992E92FD-4A6A-4716-B54B-ADB5749D0759Q34689211-202DF306-E3C5-465B-AA51-FF5099F36F59Q34770479-FDA57491-463E-4D5B-85D4-337D427B911BQ34785900-E2876ECA-17AB-43A9-B4C2-E56536312471Q35009519-106FEC71-2AE9-4EE2-AC51-1D0DBD306E2BQ35022972-B67A2868-C3B0-4071-AECF-9808F40E9424Q35117523-F530DE28-2254-4BC9-B0E6-C8D7C922F009Q35194419-FC8730A6-1E67-41CA-9EA1-AB95BAADB95AQ35544743-CAE1CBCB-3944-400E-A382-9B5C83644BC9Q35596637-C3E50D25-A4D0-40D6-8FA1-087393391159Q35651873-FB30F76C-EF52-4750-A93E-5891A1BC14C3Q35863167-812B228F-06F3-41BE-AB3C-31BA5C44C68EQ35903462-7A5609CA-46F6-4A2E-8711-6DF591C5F448Q35911160-889C9B1A-0F64-496F-B899-E6AFD92E6D9CQ35996583-5A40C06B-0B7C-45FC-A7D5-326B0D351FD2
P2860
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity.
description
1995 nĆ® lÅ«n-bĆ»n
@nan
1995幓ć®č«ę
@ja
1995幓č«ę
@yue
1995幓č«ę
@zh-hant
1995幓č«ę
@zh-hk
1995幓č«ę
@zh-mo
1995幓č«ę
@zh-tw
1995幓č®ŗę
@wuu
1995幓č®ŗę
@zh
1995幓č®ŗę
@zh-cn
name
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity.
@en
type
label
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity.
@en
prefLabel
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity.
@en
P1476
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity.
@en
P2093
B Fromenty
D Pessayre
P304
P356
10.1016/0163-7258(95)00012-6
P577
1995-01-01T00:00:00Z